CMPS logo

COMPASS Pathways (CMPS) Company Overview

Profile

Full Name:

COMPASS Pathways plc

Sector:

Healthcare

Country:

United Kingdom

IPO:

September 18, 2020

Indexes:

Not included

Description:

COMPASS Pathways is a mental health care company focused on developing innovative treatments for depression and other mental health conditions. They are known for their research on psilocybin, a compound found in mushrooms, aiming to improve therapy outcomes and provide new options for patients.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Oct 31, 2024

Recent annual earnings:

Feb 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 15, 25 RBC Capital
Outperform
Nov 1, 24 RBC Capital
Outperform
Nov 1, 24 Maxim Group
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Sep 10, 24 RBC Capital
Outperform
Sep 9, 24 Cantor Fitzgerald
Overweight
Aug 23, 24 HC Wainwright & Co.
Buy
Aug 2, 24 Canaccord Genuity
Buy
Jul 31, 24 HC Wainwright & Co.
Buy
Jul 23, 24 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Psychedelic Stocks: Focus On Their Cash
Psychedelic Stocks: Focus On Their Cash
Psychedelic Stocks: Focus On Their Cash
CMPS
seekingalpha.comAugust 15, 2024

Jason Najum covers the psychedelic space and contextualizes recent news around the FDA, MDMA, PTSD, and Lykos Therapeutics. Why it may be a blessing in disguise for Cybin, COMPASS Pathways, and MindMed despite setbacks.

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript
COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript
COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript
CMPS
seekingalpha.comAugust 4, 2024

COMPASS Pathways plc (NASDAQ:CMPS ) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Guy Goodwin - Chief Medical Officer Teri Loxam - CFO Conference Call Participants Ritu Baral - TD Cowen Leonid Timashev - RBC Capital Markets Charles Duncan - Cantor Vikram Purohit - Morgan Stanley Gavin Clark-Gartner - Evercore ISI Sumant Kulkarni - Canaccord Genuity Tom Shrader - BTIG Elemer Piros - Rodman Operator Good day, ladies and gentlemen, and welcome to COMPASS Pathways' Second Quarter 2024 Conference Call. [Operator Instructions] As a reminder, this call is being recorded.

Compass Pathways to announce first quarter financial results on May 8, 2024
Compass Pathways to announce first quarter financial results on May 8, 2024
Compass Pathways to announce first quarter financial results on May 8, 2024
CMPS
GlobeNewsWireMay 3, 2024

Compass Pathways plc, a biotechnology company focused on improving patient access to evidence-based mental health solutions, will report its financial results for the first quarter of 2024 and share recent business updates on May 8, 2024.

Penny Power Players: 3 Stocks to Watch in the Microcap Arena
Penny Power Players: 3 Stocks to Watch in the Microcap Arena
Penny Power Players: 3 Stocks to Watch in the Microcap Arena
CMPS
InvestorPlaceFebruary 27, 2024

There are some great microcap stocks for investors to scoop up this month. The broader indices, such as the S&P 500 and the Nasdaq, are showing signs of both strength and weakness, but I believe that there's still a lot of gas left in the tank for these to surge higher.

Compass Pathways to participate in upcoming TD Cowen investor conference
Compass Pathways to participate in upcoming TD Cowen investor conference
Compass Pathways to participate in upcoming TD Cowen investor conference
CMPS
GlobeNewsWireFebruary 26, 2024

LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a panel discussion at the TD Cowen 44th Annual Health Care Conference at 12:50 pm ET on March 4, 2024.

Compass Pathways to participate in upcoming Oppenheimer investor conference
Compass Pathways to participate in upcoming Oppenheimer investor conference
Compass Pathways to participate in upcoming Oppenheimer investor conference
CMPS
GlobeNewsWireJanuary 31, 2024

LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference at 2:00 pm ET on February 13, 2024.

De-Risking Psychedelics: Compass Pathways, Cybin And Atai
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
CMPS
Seeking AlphaJanuary 9, 2024

Critical catalysts are approaching in the psychedelic sector, with the potential for the first FDA-approved psychedelic therapy by the end of the year.

COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript
COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript
COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript
CMPS
Seeking AlphaNovember 4, 2023

COMPASS Pathways plc (NASDAQ:CMPS ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Company Participants Stephen Schultz - SVP, IR Kabir Nath - CEO Mary-Rose Hughes - Interim CFO Dr. Guy Goodwin - Chief Medical Officer Conference Call Participants Ritu Baral - TD Cohen Charles Duncan - Cantor François Brisebois - Oppenheimer Patrick Trucchio - H.C. Wainright Michael Okunewitch - Maxim Group Sumant Kulkarni - Canaccord Genuity Gavin Clark-Gartner - Evercore ISI Thomas Shrader - BTIG Operator Good day, ladies and gentlemen, and welcome to the COMPASS Pathways Third Quarter 2023 Conference Call.

COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023
COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023
COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023
CMPS
GlobeNewsWireOctober 24, 2023

LONDON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2023, and provide an update on recent business developments on November 2, 2023.

Don't Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher
Don't Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher
Don't Miss the Boom: 3 Psychedelic Stocks Set to Explode Higher
CMPS
InvestorPlaceSeptember 27, 2023

Psychedelic stocks are on the rise. Despite the stigma surrounding psychedelics for personal use, controlled medical experiments indicate their usefulness for treating a variety of conditions.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the ticker symbol for COMPASS Pathways?
  • Does COMPASS Pathways pay dividends?
  • What sector is COMPASS Pathways in?
  • What industry is COMPASS Pathways in?
  • What country is COMPASS Pathways based in?
  • When did COMPASS Pathways go public?
  • Is COMPASS Pathways in the S&P 500?
  • Is COMPASS Pathways in the NASDAQ 100?
  • Is COMPASS Pathways in the Dow Jones?
  • When was COMPASS Pathways's last earnings report?
  • When does COMPASS Pathways report earnings?
  • Should I buy COMPASS Pathways stock now?

What is the ticker symbol for COMPASS Pathways?

The ticker symbol for COMPASS Pathways is NASDAQ:CMPS

Does COMPASS Pathways pay dividends?

No, COMPASS Pathways does not pay dividends

What sector is COMPASS Pathways in?

COMPASS Pathways is in the Healthcare sector

What industry is COMPASS Pathways in?

COMPASS Pathways is in the Medical Care Facilities industry

What country is COMPASS Pathways based in?

COMPASS Pathways is headquartered in United Kingdom

When did COMPASS Pathways go public?

COMPASS Pathways's initial public offering (IPO) was on September 18, 2020

Is COMPASS Pathways in the S&P 500?

No, COMPASS Pathways is not included in the S&P 500 index

Is COMPASS Pathways in the NASDAQ 100?

No, COMPASS Pathways is not included in the NASDAQ 100 index

Is COMPASS Pathways in the Dow Jones?

No, COMPASS Pathways is not included in the Dow Jones index

When was COMPASS Pathways's last earnings report?

COMPASS Pathways's most recent earnings report was on Oct 31, 2024

When does COMPASS Pathways report earnings?

The next expected earnings date for COMPASS Pathways is Feb 28, 2025

Should I buy COMPASS Pathways stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions